These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8414287)

  • 41. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
    Anderson FD; Gibbons W; Portman D
    Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The European experience: an overview.
    Gillmer MD
    Int J Fertil; 1992; 37 Suppl 1():36-46. PubMed ID: 1347519
    [No Abstract]   [Full Text] [Related]  

  • 43. New contraception options.
    Smith MJ
    Diabetes Self Manag; 2004; 21(5):20-2, 25. PubMed ID: 15586908
    [No Abstract]   [Full Text] [Related]  

  • 44. Lybrel--a continuous oral contraceptive.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):61-2. PubMed ID: 17652998
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The pharmacological properties of a modified estrogen 11-nitrate-3-acetate-9 alpha, 11 beta-dioxyestrone].
    Ivanenko TI; Pokrovskaia EV; Rzheznikov EM; Fedotov VP
    Eksp Klin Farmakol; 1994; 57(2):36-9. PubMed ID: 8205046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure with the new triphasic oral contraceptive Logynon.
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):422-3. PubMed ID: 6800487
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral contraceptive-induced central retinal artery occlusion.
    Rekhi GS; Dheer S
    J Assoc Physicians India; 2002 Aug; 50():1084-5. PubMed ID: 12421041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDA approves new oral contraceptive.
    FDA Consum; 2003; 37(6):5. PubMed ID: 14983808
    [No Abstract]   [Full Text] [Related]  

  • 50. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical experiences with a gestodene containing oral contraceptive (femoden)].
    Gimes G; Valent S
    Acta Pharm Hung; 1998 Sep; 68(5):289-93. PubMed ID: 9805815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics.
    Schwartz JI; Dunbar S; Yuan J; Li S; Miller DL; Rosko K; Johnson-Levonas AO; Lasseter KC; Wagner JA
    J Clin Pharmacol; 2009 Jan; 49(1):72-9. PubMed ID: 18936284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunological studies of the vaginal secretion in women using contraceptive preparations].
    Nalbanski B; Stanislavov R
    Akush Ginekol (Sofiia); 1981; 20(4):337-40. PubMed ID: 7304853
    [No Abstract]   [Full Text] [Related]  

  • 56. Pregnancy and porphyria cutanea tarda.
    Rajka G
    Acta Derm Venereol; 1984; 64(5):444-5. PubMed ID: 6208730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Myasthenia and oral contraceptives (a case report)].
    Kiehl U
    Z Arztl Fortbild (Jena); 1984; 78(4):153-4. PubMed ID: 6711038
    [No Abstract]   [Full Text] [Related]  

  • 58. [Oxytetral and Lindynette].
    Ravnbak K
    Ugeskr Laeger; 2006 Sep; 168(39):3335; author reply 3335. PubMed ID: 17036420
    [No Abstract]   [Full Text] [Related]  

  • 59. Oral contraceptives and erythema nodosum: report of a case.
    Gelfand M
    Cent Afr J Med; 1982 Aug; 28(8):199-201. PubMed ID: 7172240
    [No Abstract]   [Full Text] [Related]  

  • 60. Continuous oral contraception. Strategies for managing breakthrough bleeding.
    Freeman SB
    Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.